- Details
- Description
Packaging Size:
As stated on the product packaging
Strength:
50 mg
Composition:
Dasatinib 50 mg
Treatment:
Certain types of leukemia, including Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and certain Ph+ acute lymphoblastic leukemia (ALL).
Form:
Tablet
Brand:
LuciDasa
Quantity Unit:
Tablets
Manufacturer:
Lucius Pharma
LuciDasa 50 (Dasatinib) is a prescription medicine used in the treatment of certain types of leukemia. It contains dasatinib, a targeted medicine that works by blocking specific proteins involved in the growth and survival of abnormal blood cells.
LuciDasa 50 is intended for oral use and should be taken according to the instructions of a qualified healthcare professional. It is used as part of the management of appropriate patients with specific leukemia conditions.
